Sales of prescription drugs in emerging markets will grow rapidly over the next few years, pharmaceutical market research firm IMS Health says, with China becoming the world's third-largest prescription drug market in 2011.
IMS says pharmaceutical revenue in China is growing at a great pace, and the market there could double by 2013 as the country improves its health care infrastructure and aims for near-universal health coverage. The firm says drug revenue there will grow by $40 billion through 2013.
IMS says growth in China has come even more quickly than it expected. In 2006, it predicted China would be the world's sixth-largest pharmaceutical market by 2011. The two largest markets are the U.S. and Japan.
© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.